TrialAmerican journal of hematology2026

A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study.

Tzu-Fei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.